COVID 19 – XXI ҒАСЫРДЫҢ ЖАҢА ИНФЕКЦИЯСЫ
Коронавирустар (CoV) - үй және ауыл шаруашылығы жануарларының (тауықтар, шошқалар, енекелер, мысықтар және иттер) жіті қабыну ауруларын тудыратын респираторлық вирустардың өзгергіш тобы. Соңғы уақытқа дейін адамдарда инфекция көбінесе күзгі-қысқы кезеңде байқалды және жеңіл ағынмен сипатталды. 2003 жылы Қытайда патогенді СоV (SARS-CoV) туындаған типтік пневмония пайда болған кезде жағдай күрт өзгерді. 10 жылдан кейін Таяу шығыс респираторлық синдромы (MERS-CoV) түрінде CoV жаңа өршуі пайда болды.
2019 жылдың желтоқсанында Жаңа коронавирус (SARS-CoV2) туындаған аурулардың пайда болуы 2020 жылдың алғашқы айларында пандемияға айналған халықаралық мағынасы бар төтенше жағдай ретінде тарихқа енді. Жаңа коронавирус оның молекулалық-биологиялық ерекшеліктері тұрғысынан ғана емес, диагностика мен емдеудің мүмкін болатын қиындықтары, клиникалық ағымның ерекшеліктері, сыни жағдайлар мен асқынулардың жоғары даму қаупі, жоғары өлім-жітім бөлігінде жаңа болып табылады. Ауру жиі құрғақ жөтелден жіті респираторлық дистресс-синдромға (ЖРДС) дейін ауытқыған ауыр бронх-өкпе зақымдануына әкеледі.
Осы хабарламада біз жаңа коронавирустың табиғатын, эпидемиологиясын, патогенезін, клиникалық көріністерін және ауруды емдеу саласында жинақталған тәжірибені көрсетуге тырыстық.
Юлия Г. Попович ¹, Рая Ж. Рахимова², Динара О. Ахметжанова¹
1 «Семей медицина университеті» ҚеАҚ, Семей қаласы, Қазақстан Республикасы;
2 «Вита-1» ЖШС Өскемен қаласы, Қазақстан Республикасы.
1. Баранова А. Коронавирус. Инструкция по выживанию.2020. М: АСТ. 90с.
2. Беляков Н.А., Рассохин В.В., Ястребова Е.Б. Коронавирусная инфекция COVID 19. Природа вируса, патогенез, клинические проявления. Сообщение 1 // ВИЧ-инфекция и иммуносупрессии. 2020. N1. С. 7-21.
3. Галкин А.А., Демидова В.С. Центральная роль нейтрофилов в патогенезе синдрома острого повреждения легких (острый респираторный синдром) // Успехи современной биологии. 2014. №4. С.377 – 394.
4. Диагностика и лечение коронавирусной инфекции COVID 19: клинический протокол, одобренный объединенной комиссией по качеству медицинских услуг МЗ РК. Протокол № 92. от 6.05.2020.
5. Клиническое ведение тяжелых острых респираторных инфекций при подозрении на коронавирусную инфекцию COVID 19: временные рекомендации ВОЗ. 13 марта 2020, Женева.
6. Коровин А.Е., Новицкий А.А., Макарова Д.А. Острый респираторный дистресс-синдром. Современное состояние проблемы // Клиническая патофизиология.2018. №2. С.32-41.
7. Никифоров В.В., Суранова Т.Г., Чернобровкина Т.Я. Новая коронавирусная инфекция (COVID 19): клинико-эпидемиологические аспекты // Архивъ внутренней медицины. 2020. №2. С.87-93.
8. Новая коронавирусная инфекция (COVID 19): этиология, эпидемиология, клиника, диагностика, лечение и профилактика / под ред. В.В. Никифорова: учебно-методическое пособие. Москва, 2020. 71с.
9. Особенности клинических проявлений и лечение заболеваний, вызванных новой коронавирусной инфекцией (COVID 19) у детей / под ред. Ю.С. Александрович: методические рекомендации МЗ РФ. Москва, 2020. 43с.
10. Светлицкая О.И., Сирош Ю.А., Блатун В.П., Кланус И.И. Риск развития острого респираторного дистресс-синдрома у пациентов с внегоспитальными вирусно-бактериальными пневмониями // Экстренная медицина. 2018. № 4. С.564- 569.
11. Симбирцев С.А., Беляков Н.А. Микроэмболии легких. Л.: Медицина, 1986. 216с.
12. Смирнов В.С., Тотолян А. Врожденный иммунитет при коронавирусной инфекции // Инфекция и иммунитет. 2020. №2. С.259-268.
13. Новый коронавирус COVID -19(SARS – CoV-2) // Детские инфекции. 2020. №1. 5-6с.
14. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID 19)/ под.ред. Е.Г. Камкина: временные методические рекомендации МЗ РФ. Москва, 2020. 164с.
15. Alserehi H., Wali G., Alshukairi A., Alraddadi B. Impact of Middle East respiratory syndrome coronavirus (MERS-CoV) on pregnancy and perinatal outcome // BMC Infect Dis. 2016. №16. Р. 105 – 108.
16. Bassetti M. The Novel Chinese Coronavirus ( 2019 – nCoV) Infections challenges for fighting the strom // Eur. J. Clin. Invest. 2020. №1. URL: https: //doi.org/10.1111/ eci13209.
17. Brunk D. CDC: First Person-to-Person Spread of Novel Coronavirus in US // Medscape Medical News. 2020. №1. URL: https://www.medscape.com/viewarticle/924571.
18. Cao B., Wang Y., Wen D. et al. A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 // New England Jurnal Medicine. 2020. №2. URL: https://www.nejm.org/doi/full/10.1056/NEJMoa2001282 (дата обращения 25.05.20)
19. Cao Q., Chen Y.C., Chen C.L., Chiu C.H. SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristics // J Formos Med Assoc. 2020. №3. Р.670–673.
20. Chan J., Yuan S., Kok K., Kai-Wang To K., Chu H., Yang J., Xing F., Liu J., et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster // Lancet. 2020. v. 395. P. 514–523.
21. Chen I-Y., Moriyama M., Chang M.-F., Ichinohe T. Severe acute respiratory syndrome coronavirus viroporin 3a activates the NLRP3 inflammasome // Front. Microbiol. 2019. vol. 10. p. 50.
22. Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., Qiu Y., Wang J., et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study // Lancet. 2020. vol. 395. Р. 507–513.
23. Dong Y., Mo X., Hu Y., Qi X., Jiang F., Jiang, Tong S. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China // Pediatrics. 2020. № 1. URL: https://pediatrics.aappublications.or text. (дата обращения 25.05.2020).
24. Gallegos A. WHO Declares Public Health Emergency for Novel Coronavirus // Medscape Medical News. 2020. №1. URL: https://www.medscape.com/viewarticle/924596. (дата обращения 24.05.20).
25. Gorbalenya A.E. Severe acute respiratory syndrome-related coronavirus — The species and its viruses, a statement of the Coronavirus Study Group // Nature Microbiology. 2020. № 2. URL: http:// doi: 10.1038/s41564-020-0695-z. (дата обращения 27.05.20).
26. Gu H., Xie Z., Li T., Zhang S., Lai C., Zhu P., Wang K., Han L., et al. Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus // Sci Rep. 2016. v.6. Р.19840.
27. Gu J., Han B., Jian Wang J. COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission // Gastroenterology. 2020. № 1. URL: https://doi.org/10.1053/j.gastro.2020.02.054/.
28. Guan W.J., Ni Z.Y., Hu Y., Liang W., Ou C., He J., Liu L., Shan H., et al. Clinical Characteristics of Coronavirus Disease 2019 in China // N. Engl. J. Med. 2020.v.382. P.1708-1720.
29. Guo H., Callaway J.B., Ting J.P.-Y. Inflammasomes: mechanism of action, role in disease, and therapeutics.// Nat. Med. 2015. № 7. P. 677–687.
30. Guo Т., Yongzhen F., Chen М., Wu Х., Zhang L., He Т., Wang H., Wan J., Wang Х., Lu Z. Cardiovascular Implications of Fatal Outcomes of Patients with Coronavirus Disease 2019 (COVID-19) // JAMA Cardiol. 2020. №1. URL: https://pubmed.ncbi.nlm.nih.gov/32219356/. (дата обращения 27.05.20).
31. Hagmann S. COVID-19 in children: More than meets the eye // Travel Medicine and Infectious Disease. 2020. №1. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195039/. (дата обращения 25.05.20).
32. Huang C., WangY., Li X., Ren L., Zhoo J., Hu Y. Clinical features of patients infected with novel coronavirus in Wuhan, China // Lancet. 2020. №1. URL: https://doi.org110.1016/S0140-6736(2)0/30183-5
33. Hui D.S., Azhar I.E., Madani T.A., Ntoumi F., Kock R., Dar O., Ippolito G., Mchugh T.D., et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China // Int. J. Infect. Dis. 2020. vol. 91. Р. 264–266.
34. Kuhn J.H., Li W., Choe H., Farzan M. Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus // Cell Mol.Life Sci. 2004. vol. 61. Р. 2738–2743.
35. Lee P.I., Hu YL., Chen P.Y., Huang Y.-C., Hsueh P.-R. Are children less susceptible to COVID-19? // J Microbiol Immunol Infect. 2020. №1. URL: https://pubmed.ncbi.nlm.nih.gov/32147409/. (дата обращения 25.05.20).
36. Liu W., Zhang Q., Chen J., Xiang R., Song H., Shu S., Chen L., Liang L., et al. Detection of COVID-19 in Children in Early January 2020 in Wuhan, China // N Engl J Med. 2020. №1. URL: https://www.nejm.org/doi/10.1056/NEJMc2003717.
37. Lu X., Zhang L., Du H., Zhang J., Li Y.Y., Qu J., Zhang W., Wang Y. et al. SARS-CoV-2 infection in children // N Engl J Med. 2020.v. 382. P. 1663 – 1665.
38. Ludvigsson J.F. Systematic review of COVID-19 in children show milder cases and a better prognosis than adults // Acta Paediatr. 2020. v.109. P. 1088 – 1095.
39. Pan L., Mu M., Yang P., Sun Y., Wang R., Yan J., Li P., Hu B., et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study // The American Journal of Gastroenterology. 2020. v.115. P.766 – 773.
40. Ramzy А., McNeil D.G. W.H.O. Declares Global Emergency as Wuhan Coronavirus Spreads // The New York Times. 2020. January 30. URL: https://nyti.ms/2RER70M.
41. Shi C.-S., Qi H.-Y., Boularan C., Huang N.-N., Abu-Asab M., Shelhamer J.H., Kehrl J.H. SARS-CoV ORF9b suppresses innate immunity by targeting mitochondria and the МAVS/TRAF3/TRAF6 signalosome // J. Immunol. 2014. vol. 193. Р. 3080-3089.
42. Wan Y., Shang J., Graham R., Baric R.S., Li F. Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS // J. Virology. 2020.v.94. URL: https://doi.org/10.1128/JVI.00127-20.( дата обращения 25.05.20).
43. Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J. et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China // JAMA. 2020. vol. 323. P. 1061 – 1069.
44. Wei M., Yuan J., Liu Y., Fu T., Yu X., Zhang Z.J. Novel Coronavirus Infection in Нospitalized Infants Under 1 Year of Age in China // JAMA.2020. vol.323. P. 1313-1314.
45. Wu C., Chen X., Cai Y., Xia J., Zhou X., Xu S, Huang H., Zhang L., et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China // JAMA Intern. Med. 2020. №1. URL: https://jamanetwork.com/ on 05/28/2020. (дата обращения 27.05.20).
46. Xia W, Shao J., Guo Y., Peng X., Li Z., Hu D. Clinical and CT features in pediatric patients with COVID‐19 infection: Different points from adults // Pediatr. Pulmonol.2020.vol.55. P. 1169-1174.
47. Zhang L., Lin D., Sun X., Curth U., Drosten C., Sauerhering L., Becker S., Rox K., Hilgenfeld R. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors // Science. 2020. vol. 368. P.409 – 412.
48. Zhang Y.P. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China // Chin J Epidemiol. 2020. vol. 41. P. 145-151.
References:
1. Baranova A. Koronavirus. Instruktsiya po vyzhivaniyu [Coronavirus. Survival guide]. 2020. M: AST. 90p. [in Russian].
2. Belyakov N.A., Rassokhin V.V., Yastrebova E.B. Koronavirusnaya infektsiya COVID 19. Priroda virusa, patogenez, klinicheskie proyavleniya. Soobshchenie 1 [Coronavirus infectious disease COVID 19. Nature of virus, pathogenesis, clinical manifestations. Message 1]. VICh-infektsiya i immunosupressii [HIV Infection and Immunosupressive Disoders]. 2020. N1. pp. 7-21. [in Russian].
3. Galkin A.A., Demidova V.S. Tsentral'naya rol' neitrofilov v patogeneze sindroma ostrogo povrezhdeniya legkikh (ostryi respiratornyi sindrom) [The central role of neutrophils in the pathogenesis of acute lung injury syndrome (acute respiratory distress syndrome)]. Uspekhi sovremennoi biologii [Advances in modern biology]. 2014. №4. pp.377 – 394. [in Russian]
4. Diagnostika i lechenie koronavirusnoi infektsii COVID 19: klinicheskii protokol, odobrennyi ob"edinennoi komissiei po kachestvu meditsinskikh uslug MZ RK. Protokol № 92. ot 6.05.2020 [Diagnosis and treatment of coronaviruous infection COVID 19: clinical protocol approved by the Joint Commission on the Quality of Medical Services of the Ministry of Health of the Republic of Kazakhstan. Minutes 92 dated 6.05.2020]. [in Russian]
5. Klinicheskoe vedenie tyazhelykh ostrykh respiratornykh infektsii pri podozrenii na koronavirusnuyu infektsiyu COVID 19: vremennye rekomendatsii VOZ. 13 marta 2020, Zheneva [Clinical management of severe acute respiratory infections for suspected coronavirus infection: interim WHO guidelines. 13 March 2020, Geneva]. [in Russian]
6. Korovin A.E., Novitskii A.A., Makarova D.A. Ostryi respiratornyi distress-sindrom. Sovremennoe sostoyanie problemy [Acute respiratory distress syndrome. Current state of the problem. Klinicheskaya patofiziologiya]. Klinicheskaya patofiziologiya [Clinical pathophysiology]. 2018. №2. pp. 32-41. [in Russian]
7. Nikiforov V.V., Suranova T.G., Chernobrovkina T.Ya. Novaya koronavirusnaya infektsiya (COVID 19): kliniko-epidemiologicheskie aspekty [New Coronavirus Infection (COVID 19): Clinical and ehidemiological aspects]. Arkhiv" vnutrennei meditsiny [The Russian Archives of Internal Medicine]. 2020. №2. pp.87-93. [in Russian]
8. Novaya koronavirusnaya infektsiya (COVID 19): etiologiya, epidemiologiya, klinika, diagnostika, lechenie i profilaktika [New Coronavirus Infection (COVID 19): etiology, epidemiology, clinic, diagnosis, treatment and prevention. Uchebno-metodicheskoe posobie pod red. V.V. Nikiforova. Moskva, 2020. 71p.]. Uchebno-metodicheskoe posobie pod red. V.V. Nikiforova. Moskva, 2020. 71p. [in Russian]
9. Osobennosti klinicheskikh proyavlenii i lechenie zabolevanii, vyzvannykh novoi koronavirusnoi infektsiei (COVID 19) u detei [Features of clinical manifestations and treatment of disease caused by a new coronavirus infection (COVID 19) in children]. Metodicheskie rekomendatsii pod red. Yu.S. Aleksandrovich. MZ RF. Moskva, 2020. 43p. [in Russian]
10. Svetlitskaya O.I., Sirosh Yu.A., Blatun V.P., Klanus I.I. Risk razvitiya ostrogo respiratornogo distress-sindroma u patsientov s vnegospital'nymi virusno-bakterial'nymi pnevmoniyami [The risk developing acute respiratory distress syndrome in patients with community-acquired viral–bacterial pneumonia]. Ekstrennaya meditsina [Emergency medicine]. 2018. № 4. pp.564- 569. [in Russian]
11. Simbirtsev S.A., Belyakov N.A. Mikroembolii legkikh [Microembolism of the lungs]. L.: Meditsina, 1986. 216 p. [in Russian]
12. Smirnov V.S., Totolyan A. Vrozhdennyi immunitet pri koronavirusnoi infektsii []. Innate immunity in coronavirus infection]. Infektsiya i immunitet [Infection and Immunity]. 2020. №2. pp.259-268. [in Russian]
13. Novyi koronavirus COVID -19(SARS – CoV-2) [The new coronavirus COVID 19 (SARS – CoV-2) (SARS – CoV-2)]. Detskie infektsii [Childhood infections]. 2020. №1. 5-6p. [in Russian]
14. Profilaktika, diagnostika i lechenie novoi koronavirusnoi infektsii (COVID 19). [Prevention, diagnosis and treatment of new coronavirus infection (COVID 19)]. Vremennye metodicheskie rekomendatsii MZ RF. pod.red. E.G. Kamkina. Moskva, 2020. 164p. [in Russian]
15. Alserehi H., Wali G., Alshukairi A., Alraddadi B. Impact of Middle East respiratory syndrome coronavirus (MERS-CoV) on pregnancy and perinatal outcome. BMC Infect Dis. 2016. №16. Р. 105 – 108.
16. Bassetti M. The Novel Chinese Coronavirus (2019 – nCoV) Infections challenges for fighting the strom. Eur. J. Clin. Invest. 2020. №1. URL: https: //doi.org/10.1111/ eci13209.
17. Brunk D. CDC: First Person-to-Person Spread of Novel Coronavirus in US. Medscape Medical News. 2020. №1. URL: https://www.medscape.com/viewarticle/924571.
18. Cao B., Wang Y., Wen D. et al. A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 // New England Jurnal Medicine. 2020. №2. URL: https://www.nejm.org/doi/full/10.1056/NEJMoa2001282 (дата обращения 25.05.20)
19. Cao Q., Chen Y.C., Chen C.L., Chiu C.H. SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristics. J Formos Med Assoc. 2020. №3. Р.670–673.
20. Chan J., Yuan S., Kok K., Kai-Wang To K., Chu H., Yang J., Xing F., Liu J., et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020. v. 395. P. 514–523.
21. Chen I-Y., Moriyama M., Chang M.-F., Ichinohe T. Severe acute respiratory syndrome coronavirus viroporin 3a activates the NLRP3 inflammasome. Front. Microbiol. 2019. vol. 10. p. 50.
22. Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., Qiu Y., Wang J., et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020. vol. 395. Р. 507–513.
23. Dong Y., Mo X., Hu Y., Qi X., Jiang F., Jiang, Tong S. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics. 2020. № 1. URL: https://pediatrics.aappublications.or text. (дата обращения 25.05.2020).
24. Gallegos A. WHO Declares Public Health Emergency for Novel Coronavirus. Medscape Medical News. 2020. №1. URL: https://www.medscape.com/viewarticle/924596. (дата обращения 24.05.20).
25. Gorbalenya A.E. Severe acute respiratory syndrome-related coronavirus — The species and its viruses, a statement of the Coronavirus Study Group. Nature Microbiology. 2020. № 2. URL: http:// doi: 10.1038/s41564-020-0695-z. (дата обращения 27.05.20).
26. Gu H., Xie Z., Li T., Zhang S., Lai C., Zhu P., Wang K., Han L., et al. Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus. Sci Rep. 2016. v.6. Р.19840.
27. Gu J., Han B., Jian Wang J. COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology. 2020. № 1. URL: https://doi.org/10.1053/j.gastro.2020.02.054/.
28. Guan W.J., Ni Z.Y., Hu Y., Liang W., Ou C., He J., Liu L., Shan H., et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N. Engl. J. Med. 2020.v.382. P.1708-1720.
29. Guo H., Callaway J.B., Ting J.P.-Y. Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat. Med. 2015. № 7. P. 677–687.
30. Guo Т., Yongzhen F., Chen М., Wu Х., Zhang L., He Т., Wang H., Wan J., Wang Х., Lu Z. Cardiovascular Implications of Fatal Outcomes of Patients with Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020. №1. URL: https://pubmed.ncbi.nlm.nih.gov/32219356/. (дата обращения 27.05.20).
31. Hagmann S. COVID-19 in children: More than meets the eye. Travel Medicine and Infectious Disease. 2020. №1. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195039/. (дата обращения 25.05.20).
32. Huang C., WangY., Li X., Ren L., Zhoo J., Hu Y. Clinical features of patients infected with novel coronavirus in Wuhan, China. Lancet. 2020. №1. URL: https://doi.org110.1016/S0140-6736(2)0/30183-5
33. Hui D.S., Azhar I.E., Madani T.A., Ntoumi F., Kock R., Dar O., Ippolito G., Mchugh T.D., et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China. Int. J. Infect. Dis. 2020. vol. 91. Р. 264–266.
34. Kuhn J.H., Li W., Choe H., Farzan M. Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus. Cell Mol.Life Sci. 2004. vol. 61. Р. 2738–2743.
35. Lee P.I., Hu YL., Chen P.Y., Huang Y.-C., Hsueh P.-R. Are children less susceptible to COVID-19? J Microbiol Immunol Infect. 2020. №1. URL: https://pubmed.ncbi.nlm.nih.gov/32147409/. (дата обращения 25.05.20).
36. Liu W., Zhang Q., Chen J., Xiang R., Song H., Shu S., Chen L., Liang L., et al. Detection of COVID-19 in Children in Early January 2020 in Wuhan, China. N Engl J Med. 2020. №1. URL: https://www.nejm.org/doi/10.1056/NEJMc2003717.
37. Lu X., Zhang L., Du H., Zhang J., Li Y.Y., Qu J., Zhang W., Wang Y. et al. SARS-CoV-2 infection in children. N Engl J Med. 2020.v. 382. P. 1663 – 1665.
38. Ludvigsson J.F. Systematic review of COVID-19 in children show milder cases and a better prognosis than adults. Acta Paediatr. 2020. v.109. P. 1088 – 1095.
39. Pan L., Mu M., Yang P., Sun Y., Wang R., Yan J., Li P., Hu B., et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. The American Journal of Gastroenterology. 2020. v.115. P.766 – 773.
40. Ramzy А., McNeil D.G. W.H.O. Declares Global Emergency as Wuhan Coronavirus Spreads. The New York Times. 2020. January 30. URL: https://nyti.ms/2RER70M.
41. Shi C.-S., Qi H.-Y., Boularan C., Huang N.-N., Abu-Asab M., Shelhamer J.H., Kehrl J.H. SARS-CoV ORF9b suppresses innate immunity by targeting mitochondria and the МAVS/TRAF3/TRAF6 signalosome. J. Immunol. 2014. vol. 193. Р. 3080-3089.
42. Wan Y., Shang J., Graham R., Baric R.S., Li F. Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS. J. Virology. 2020. v.94. URL: https://doi.org/10.1128/JVI.00127-20. (дата обращения 25.05.20).
43. Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J. et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020. vol. 323. P. 1061 – 1069.
44. Wei M., Yuan J., Liu Y., Fu T., Yu X., Zhang Z.J. Novel Coronavirus Infection in Нospitalized Infants Under 1 Year of Age in China. JAMA. 2020. vol.323. P. 1313-1314.
45. Wu C., Chen X., Cai Y., Xia J., Zhou X., Xu S, Huang H., Zhang L., et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern. Med. 2020. №1. URL: https://jamanetwork.com/ on 05/28/2020. (дата обращения 27.05.20).
46. Xia W., Shao J., Guo Y., Peng X., Li Z., Hu D. Clinical and CT features in pediatric patients with COVID‐19 infection: Different points from adults. Pediatr. Pulmonol. 2020.vol.55. P. 1169-1174.
47. Zhang L., Lin D., Sun X., Curth U., Drosten C., Sauerhering L., Becker S., Rox K., Hilgenfeld R. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Science. 2020. vol. 368. P.409 – 412.
48. Zhang Y.P. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Chin J Epidemiol. 2020. vol. 41. P. 145-151.
Көрген адамдардың саны: 216
Мақалалар санаты:
COVID-19 - өзекті тақырып
Библиографиялық сілтемелер
Попович Ю.Г., Рахимова Р.Ж., Ахметжанова Д.О. COVID19 XXI ғасырдың жаңа инфекциясы // Ғылым және Денсаулық сақтау. 2020. 4 (Т.22). Б. 15-23. doi:10.34689/SH.2020.22.4.002Ұқсас жариялымдар:
COVID-19 КОРОНАВИРУСТЫҚ ИНФЕКЦИЯСЫ БАР ПАЦИЕНТТЕРДІ КЕШЕНДІ ЕМДЕУДЕГІ РЕМДЕСИВИР ВИРУСҚА ҚАРСЫ ПРЕПАРАТЫНЫҢ КЛИНИКАЛЫҚ ТИІМДІЛІГІ
COVID-19 ПАНДЕМИЯСЫ КЕЗЕҢІНДЕГІ МЕДИЦИНАЛЫҚ ҚАУІПСІЗДІК. ӘДЕБИЕТТІК ШОЛУ
ҚАЗАҚСТАН РЕСПУБЛИКАСЫНДА ОНКОЛОГИЯЛЫҚ НАУҚАСТАР АРАСЫНДАҒЫ КОРОНАВИРУСТЫҚ ИНФЕКЦИЯНЫҢ КЛИНИКАЛЫҚ ЕРЕКШЕЛІКТЕРІ
COVID 19 – XXI ҒАСЫРДЫҢ ЖАҢА ИНФЕКЦИЯСЫ
КОРОНАВИРУСТЫҚ ИНФЕКЦИЯ ПАНДЕМИЯСЫ КЕЗІНДЕГІ МЕДИЦИНА СТУДЕНТТЕР АРАСЫНДАҒЫ ЭМОЦИОНАЛДЫ РЕАКЦИЯСЫ МЕН КҮРЕСУ СТРАТЕГИЯСЫ: КӨЛДЕНЕҢ ОНЛАЙН ЗЕРТТЕУ